ArticleCell reports. Medicine2023

A kinome-wide CRISPR screen identifies CK1α as a target to overcome enzalutamide resistance of prostate cancer.

Jinghui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.